Use of prolonged treatment and the fluctuation test to detect mutations in human fibroblasts treated with methyl methanesulfonate.
The methyl methanesulfonate (MMS) induction of 6-thioguanine-resistant (6TGr) mutants in non-synchronized human fibroblasts has been quantitatively characterized. A 24-h MMS treatment failed to induce mutations in non-synchronized cultures. However, exposure of growing cells to MMS for 3 days caused a significant increase in the mutation frequencies. The mutation induction was dose-dependent. The fluctuation test was also useful in detecting the mutagenic activity of MMS in human fibroblasts. Prolonged treatment of cultures made the human cell mutagenesis testing system more sensitive.